Cargando…
Bead-Selected Antitumor Genetic Cell Vaccines
Cancer vaccines have always been in the scope of gene therapy research. One of the most successful approaches has been working with genetically modified tumor cells. However, to become a clinical reality, tumor cells must suffer a long and risky process from the extraction from the patient to the re...
Autores principales: | Herrero, MJ, R, Botella, R, Algás, Marco, FM, Aliño, SF |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161647/ https://www.ncbi.nlm.nih.gov/pubmed/21892287 |
Ejemplares similares
-
Antitumor Cell-Complex Vaccines Employing Genetically Modified Tumor Cells and Fibroblasts
por: Miguel, Antonio, et al.
Publicado: (2014) -
Comparative Antitumor Effect of Preventive versus Therapeutic Vaccines Employing B16 Melanoma Cells Genetically Modified to Express GM-CSF and B7.2 in a Murine Model
por: Miguel, Antonio, et al.
Publicado: (2012) -
Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma
por: Miguel, Antonio, et al.
Publicado: (2017) -
Joint epitope selection and spacer design for string-of-beads vaccines
por: Dorigatti, Emilio, et al.
Publicado: (2020) -
Multicompartmental Lipopolyplex as Vehicle for Antigens and Genes Delivery in Vaccine Formulations
por: Sanmartín, Isaías, et al.
Publicado: (2021)